One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Global Bioabsorbable Stents Market

世界の生体吸収性ステント市場市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Global Bioabsorbable Stents Market Outlook 2030


Product Code : Research NesterHC00116086
Survey : Research Nester
Publish On : November, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Abbott, Elixir Medical Corporation, BIOTRONIK SE & Co KG, Arterius Limited, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., OrbusNeich Medical Company Limited, Lepu Medical Technology (Beijing) Co., Ltd.

[Report Description]

Global Bioabsorbable Stents Market Analysis 2020-2030

Bioabsorbable stents are used to open or widen clogged heart arteries. The global bioabsorbable stents market is anticipated to grow with a CAGR of 7.67% over the forecast period, i.e., 2021 – 2030. Factors such as the growing prevalence of cardiovascular diseases (CVDs) worldwide, and the rising use of stents for the surgery of these diseases, followed by the growing utilization of advanced medical devices for treating chronic diseases, as well as the rising advancements in the field of healthcare, are expected to contribute to the market growth in the coming years. Furthermore, factors such as the increasing utilization of bioabsorbable stents for other medical applications, such as for preventing urine retention during benign prostatic hyperplasia (BPH), for the management of tracheobronchial obstruction, as well as for its use in the esophagus and gastrointestinal tract as a minimally invasive alternative to surgery are also expected to accelerate the market growth in the coming years. The global bioabsorbable stents market is estimated to garner a revenue of close to USD 590 Million by the end of 2030, up from a revenue of about USD 280 Million in the year 2020.
The global bioabsorbable stents market is segmented by numerous segments, which include segmentation by product type, absorption rate, application, end-users, and by region. On the basis of end-users, the market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. Amongst these, the hospitals segment is expected to generate the largest revenue of over USD 260 Million by the end of 2030, and also grow with the second-highest CAGR of 8% approximately during the forecast period.
Based on region, the global bioabsorbable stents market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in Europe region is anticipated to garner the largest revenue of near to USD 250 Million by the end of 2030, up from close to USD 130 Million in 2020.
Some of the prominent industry leaders in the global bioabsorbable stents market that are included in our report are Abbott, Elixir Medical Corporation, BIOTRONIK SE & Co KG, Arterius Limited, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., OrbusNeich Medical Company Limited, Lepu Medical Technology (Beijing) Co., Ltd., and others.

Global Bioabsorbable Stents Market TOC

1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary – Global Bioabsorbable Stents Market
5. Industry Value Chain Analysis
6. Market Dynamics
6.1. Market Drivers
6.2. Market Trends
7. Key Market Opportunities
8. Major Roadblocks for the Market Growth
9. Regulatory and Standards Landscape
10. Industry Risk Analysis
11. Average Pricing Analysis
12. Industry Growth Outlook
13. Competitive Landscape
13.1. Competitive Positioning
13.2. Market Share Analysis, 2020
13.3. Company Profiles
13.3.1. Abbott
13.3.2. Elixir Medical Corporation
13.3.3. BIOTRONIK SE & Co KG
13.3.4. Arterius Limited
13.3.5. Boston Scientific Corporation
13.3.6. Meril Life Sciences Pvt. Ltd.
13.3.7. OrbusNeich Medical Company Limited
13.3.8. Lepu Medical Technology (Beijing) Co., Ltd.
14. Global Bioabsorbable Stents Market 2020-2030
14.1. Market Overview
14.2. By Value (USD Million)
15. Global Bioabsorbable Stents Market – Segmentation Analysis 2020-2030
15.1. Product Type
15.1.1. Bioresorbable Polymer-Based Stents, 2020-2030F (USD Million)
15.1.2. Bioresorbable Metallic Stents, 2020-2030F (USD Million)
15.2. Absorption Rate
15.2.1. Slow Absorption Stents, 2020-2030F (USD Million)
15.2.2. Fast Absorption Stents, 2020-2030F (USD Million)
15.3. Application
15.3.1. Coronary Artery Diseases, 2020-2030F (USD Million)
15.3.2. Peripheral Artery Diseases, 2020-2030F (USD Million)
15.3.2.1. Carotid Artery, 2020-2030F (USD Million)
15.3.2.2. Aorta Artery, 2020-2030F (USD Million)
15.4. End-User
15.4.1. Hospitals, 2020-2030F (USD Million)
15.4.2. Ambulatory Surgical Centers, 2020-2030F (USD Million)
15.4.3. Cardiac Centers, 2020-2030F (USD Million)
15.4.4. Others, 2020-2030F (USD Million)
15.5. Region
15.5.1. North America, 2020-2030F (USD Million)
15.5.2. Europe, 2020-2030F (USD Million)
15.5.3. Asia Pacific, 2020-2030F (USD Million)
15.5.4. Latin America, 2020-2030F (USD Million)
15.5.5. Middle East & Africa, 2020-2030F (USD Million)
16. North America Bioabsorbable Stents Market
16.1. Market Overview
16.2. Market Value (USD Million)
16.3. Market Segmentation by:
16.4. Product Type
16.4.1. Bioresorbable Polymer-Based Stents, 2020-2030F (USD Million)
16.4.2. Bioresorbable Metallic Stents, 2020-2030F (USD Million)
16.5. Absorption Rate
16.5.1. Slow Absorption Stents, 2020-2030F (USD Million)
16.5.2. Fast Absorption Stents, 2020-2030F (USD Million)
16.6. Application
16.6.1. Coronary Artery Diseases, 2020-2030F (USD Million)
16.6.2. Peripheral Artery Diseases, 2020-2030F (USD Million)
16.6.2.1. Carotid Artery, 2020-2030F (USD Million)
16.6.2.2. Aorta Artery, 2020-2030F (USD Million)
16.7. End-User
16.7.1. Hospitals, 2020-2030F (USD Million)
16.7.2. Ambulatory Surgical Centers, 2020-2030F (USD Million)
16.7.3. Cardiac Centers, 2020-2030F (USD Million)
16.7.3.1. Others, 2020-2030F (USD Million)
16.7.4. Country
16.7.4.1. United States
16.7.4.2. Canada
17. Europe Bioabsorbable Stents Market
17.1. Market Overview
17.2. Market Value (USD Million)
17.3. Market Segmentation by:
17.3.1. Product Type
17.3.2. Absorption Rate
17.3.3. Application
17.3.4. End-Users
17.3.5. Country
17.3.5.1. Germany
17.3.5.2. United Kingdom
17.3.5.3. France
17.3.5.4. Italy
17.3.5.5. Spain
17.3.5.6. Russia
17.3.5.7. Netherlands
17.3.5.8. Rest of Europe
18. Asia Pacific Bioabsorbable Stents Market
18.1. Market Overview
18.2. Market Value (USD Million)
18.3. Market Segmentation by:
18.3.1. Product Type
18.3.2. Absorption Rate
18.3.3. Application
18.3.4. End-Users
18.3.5. Country
18.3.5.1. India
18.3.5.2. China
18.3.5.3. Japan
18.3.5.4. South Korea
18.3.5.5. Australia
18.3.5.6. Singapore
18.3.5.7. Rest of Asia Pacific
19. Latin America Bioabsorbable Stents Market
19.1. Market Overview
19.2. Market Value (USD Million)
19.3. Market Segmentation by:
19.3.1. Product Type
19.3.2. Absorption Rate
19.3.3. Application
19.3.4. End-Users
19.3.5. Country
19.3.5.1. Brazil
19.3.5.2. Argentina
19.3.5.3. Mexico
19.3.5.4. Rest of Latin America
20. Middle East & Africa Bioabsorbable Stents Market
20.1. Market Overview
20.2. Market Value (USD Million)
20.3. Market Segmentation by:
20.3.1. Product Type
20.3.2. Absorption Rate
20.3.3. Application
20.3.4. End-Users
20.3.5. Country
20.3.5.1. GCC
20.3.5.2. Israel
20.3.5.3. South Africa
20.3.5.4. Rest of Middle East & Africa

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+